My Alcon | Canada

This page is available in English. Select below for other countries.

Select Another Country

 

Clareon® Monofocal IOL

 

SEE DIFFERENTLY, exceptional clarity that lasts1,2*

 

Clareon® Monofocal IOL

 

SEE DIFFERENTLY, exceptional clarity that lasts1,2*

 

 

Clareon® Clareon® Monofocal IOLs provide exceptional clarity*, allowing you to confidently deliver the long-lasting refractive outcomes that 
your monofocal patients expect.1,2 

Alt text
Alt text

Exceptional Clarity that Lasts1,2*
 

Delivers among the lowest levels of glistenings, SSNGs, and surface haze.1-4* In long-term clinical studies, Clareon® IOLs were reported as glistening-free over 3 and 9 years.2,5*

Alt text
Alt text

Proprietary Precision Edge Design6-8
 

Proprietary edge curvature designed to help reduce PCO and edge glare6-8

Alt text
Alt text

Superior Axial Stability7,9,10

 

 

Fibronectin helps bind the material to the capsule, anchoring the lens in place to help reduce PCO and improve stability.8,10,11

Alt text
Alt text

Optical Design with Proven Performance7,12

 

Clareon® and AcrySof® share the same -0.2µm aspheric design resulting in improved depth of focus with a fully usable 6mm optic.12††

See the difference 
CLAREON® can make

 

 

New advanced manufacturing process combines a proprietary precision edge design with the exceptional BioOptics and BioMechanics of all Alcon IOLs.11,13

No significant difference in range of vision was observed between Clareon® and Eyhance monofocals

 

In a clinical study of 310 patients (155 per group), Clareon® and Eyhance IOLs offered comparable binocular range of vision14§

Gray Background Image of man by the ocean

§Based on a non-interventional, examiner masked comparative study (n=155 per group) on binocular visual acuities in distance, intermediate and defocus curves. Non-inferiority (1 EDTRS line) confirmed with step down statistical of multiple VA. ‡ Trademarks are the property of their respective owners.​

Clareon® IOLs: Consistent outcomes you can trust

 

Based on two studies with a total of 184 patients, Clareon® IOLs deliver predictable range of vision while maintaining 20/20 
visual acuity at distance14,15

Gray Background Image of man by the ocean

Explore additional resources for the Clareon® Monofocal IOL

The Clareon® collection provides more options for more patients

Alt text
Alt text

Clareon® Toric IOL

 

Manage astigmatism with outstanding axial and rotational stability.9

Alt text
Alt text

Clareon® PanOptix® IOL

 

Our latest advancements in lens technology, offering a full range of vision and exceptional clarity.16,17†

Alt text
Alt text

Clareon® Vivity® IOL

 

The first and only non-diffractive presbyopia-mitigating technology with exceptional clarity.1,18†

Share our lens selection guide with your patients to help educate them on their Clareon® collection options

See Things Differently

Available on Clareon®: Alcon’s most advanced IOL biomaterial to date

* Defined as modified Miyata grade 0, <25mv /mm2 over 3 years (n=138 ), and over 9 years (n=20 ), respectively.

† Based on in vitro examinations of glistenings, surface haze and SSNGs.

†† Clareon® and AcrySof® share the same -0.2μm aspheric design resulting in improved depth of focus.


 

IMPORTANT PRODUCT INFORMATION - CLAREON® ASPHERIC FAMILY OF HYDROPHOBIC ACRYLIC IOLS 


The Clareon® Aspheric Hydrophobic Acrylic IOL is a foldable single-piece posterior chamber IOL intended as an optical implant for the replacement of the human crystalline lens in the visual correction of aphakia in adult patients following cataract surgery. The Clareon® Toric Aspheric Hydrophobic Acrylic IOL is used for visual correction of pre-existing corneal astigmatism to reduce residual refractive cylinder and improve uncorrected distance vision in adult patients in whom a cataractous lens has been removed. 



 

Refer to the eDirections for Use for more information regarding indications, contraindications, warnings, precautions, and cautions.

REFERENCES:

 

  1. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL. J Cataract Refract Surg. 2019;45:1490-1497.
  2. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl meth-acrylate. J Cataract Refract Surg. 2020 May;46(5):682-687.
  3. Alcon Data on File, 2020.
  4. Stanojcic N, OʼBrart D, Hull C, et al. Visual and refractive outcomes and glistenings occurrence after implantation of 2 hydrophobic acrylic aspheric monofocal IOLs. J Cataract Refract Surg. 2020;46(7):986-994.
  5. Maxwell A, Suryakumar R. Long-term effectiveness and safety of a three-piece acrylic hydrophobic intraocular lens modified with hydroxyethyl-methacrylate: an open-label, 3-year follow-up study. Clin Ophthalmol. 2018;12:2031-2037.
  6. Alcon Data on File, 2017.
  7. Clareon® IOL Directions for Use.
  8. Das KK, Werner L, Collins S, Hong X. In vitro and schematic model eye assessment of glare or positive dysphotopsia-type photic phenomena: Comparison of a new material IOL to other monofocal IOLs. J Cataract Refract Surg. 2019;45(2):219-227.
  9. Clareon® Toric Directions for Use.
  10. Alcon data on file, 2017.
  11. Alcon data on file, 2017.
  12. Alcon data on file, 2015.
  13. Lehmann R, Maxwell A, Lubeck DM, Fong R, Walters TR, Fakadej A. Effectiveness and Safety of the Clareon® Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample. Clin Ophthalmol. 2021;15:1647-1657.
  14. Alcon Data on File, 2023.
  15. Alcon Data on File, 2022.
  16. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL Model CNWTT0 2021 Directions for Use.
  17. Zhu D, Ren S, Mills K, Hull J, Dhariwal M. Rate of Complete Spectacle Independence with a Trifocal Intraocular Lens: A Systematic Literature Review and Meta-Analysis. Ophthalmol Ther. 2023;12(2):1157-1171.
  18. Clareon® Vivity® Extended Vision Hydrophobic IOL (CNWET0) Directions for Use.